精選文獻

Straumann® Emdogain®

Straumann® Emdogain® 是一種蛋白質基質的凝膠,可以促進因牙周炎而缺失的牙周硬組織和軟組織的再生,從而保護牙齒。共有 200 多篇臨床文獻顯示了本產品具有可預測且外觀自然的治療效果,其中包括長達十年的效果,而且可安全有效地刺激新牙周附著組織的形成(牙周韌帶、牙骨質和牙槽骨)。

Twenty years of enamel matrix derivative: the past, the present and the future. Miron RJ, Sculean , Cochran DL, Froum S, Zucchelli G, Nemcovsky C, Donos N, Lyngstadaas SP, Deschner J, Dard M, Stavropoulos A, Zhang Y, Trombelli L, Kasaj A, Shirakata Y, Cortellini P, Tonetti M, Rasperini G, Jepsen S, Bosshardt DD.  J Clin Periodontol.2016 Aug;43(8):668-83. 

Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. J Clin Periodontol.2008 Sep;35(9):817-24. 

Periodontal regeneration - intrabony defects: a systematic review from the AAP Regeneration Workshop. Kao RT, Nares S, Reynolds MA.J Periodontol.2015 Feb;86(2 Suppl):S77-104. 

Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). Sculean A, Chiantella GC, Windisch P, Donos N. Int J Periodontics Restorative Dent.2000;20:374–381.

Clinical concepts for regenerative therapy in furcations. Sanz M, Jepsen K, Eickholz P, Jepsen S. Periodontol 2000.2015 Jun;68(1):308-32. 

A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars.Part I: Study design and results for primary outcomes. Jepsen S, Heinz B, Jepsen K, Arjomand M, Hoffmann T, Richter S, Reich E, Sculean A, Gonzales JR, Bödeker RH, Meyle J. J Periodontol.2004 Aug;75(8):1150-60..

Enamel matrix derivative, inflammation and soft tissue wound healing. Miron RJ, Dard M, Weinreb M. J Periodontal Res.2015 Oct;50(5):555-69.

不保證此資訊的完整性。